Issued: 12/12/11
Region: Northeast
Category: Drug 483s
Inspection date range: 11/8/11-12/12/11
Pages: 6
Company: IntelliCell Biosciences, Inc.
30 East 76th St.
6th Floor
New York, NY 10021
Inspector(s): Irina Gaberman
Observations: Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and written.
For unlimited access to our full database of Form 483s please contact customer service toll free at (888) 838-5578 or send an email to customerservice@fdanews.com.